American Journal of Tropical Medicine and Hygiene · 2024 · 10 citations · 13 references
MedicineInternal MedicineClinical EpidemiologyDiabetologyTemporal EpidemiologyBlood Glucose MonitoringContinuous Glucose MonitoringDiabetes ManagementDiabetes MellitusGlycemic ControlGlycemic MonitoringAntidiabetic Drug TherapyBlood Glucose RegulationDiabetes Medication UseDiabetes Mellitus ManagementDiabetes-related ComplicationsDiabetic ComplicationsInfection Risk FactorsTransmission Risk Factors
Although the short-term mortality of patients with COVID-19 infection and hyperglycemia has been well documented, there is little available data regarding longer-term prognosis. The presence of diabetes has not only influenced disease severity but has also impacted its transmission dynamics. In this study, we followed a historical cohort of patients without previous history of diabetes who presented with moderate to severe COVID-19 and were found to have hyperglycemia (random blood glucose > 140 mg/dL) at the time of admission. We evaluated the need for antidiabetic therapy in these patients at the end of 6 months and the risk factors associated with persistent hyperglycemia determined by monthly values of self-monitored blood glucose. Of the seventy participants who were followed telephonically, 54 (77%) continued to receive antidiabetic therapy or have persistent hyperglycemia (> 140 mg/dL) at the end of 6 months. Persistent hyperglycemia at the end of follow-up, was found to be associated with a higher blood glucose at presentation.
13
High-dimensional characterization of post-acute sequelae of COVID-19
Ziyad Al‐Aly, Yan Xie, Benjamin Bowe · Nature · 2021 · 1.6K citations · Full text
New-Onset Diabetes in Covid-19
Francesco Rubino, Stephanie A. Amiel, Paul Zimmet et al. · New England Journal of Medicine · 2020 · 828 citations
Huiqing Li, Shenghua Tian, Ting Chen et al. · Diabetes Obesity and Metabolism · 2020 · 277 citations · Full text